Giant Biogene Holding Co. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Chicmax Cosmetics Co., Ltd.

Hengan International Group Co., Ltd.

L'Occitane International SA

Giant Biogene Holding Co. Ltd.

Vinda International Holdings Ltd.

Blue Moon Group Holdings Ltd.

Natural Beauty Bio-Technology Ltd.

China Ludao Technology Co. Ltd.

Evergreen Products Group Ltd.

Precious Dragon Technology Holdings Ltd.

China Golden Classic Group Ltd.

Why is Giant Biogene Holding Co. Ltd. ?

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

High Debt Company with a Debt to Equity ratio (avg) at times

With ROE of 0.03%, it has a Very Expensive valuation with a 7.39 Price to Book Value

Over the past year, while the stock has generated a return of -34.21%, its profits have risen by 23.8%

Below par performance in long term as well as near term

Along with generating -34.21% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Giant Biogene Holding Co. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Giant Biogene Holding Co. Ltd.

-34.21%

-0.59

52.20%

Hang Seng Hong Kong

27.36%

1.06

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

22.36%

EBIT Growth (5y)

33.69%

EBIT to Interest (avg)

2.64

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.82

Sales to Capital Employed (avg)

13.17

Tax Ratio

37.90%

Dividend Payout Ratio

28.91%

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

24424

Industry P/E

Price to Book Value

7.39

EV to EBIT

14376.83

EV to EBITDA

13475.56

EV to Capital Employed

37.21

EV to Sales

539.16

PEG Ratio

Dividend Yield

ROCE (Latest)

0.26%

ROE (Latest)

0.03%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Giant Biogene Holding Co. Ltd.

Net Sales

Highest at HKD 3,252.68 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (HKD MM)

Net Sales

At HKD 3,252.68 MM has Grown at 56.94%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (HKD MM)

Operating Profit

Highest at HKD 1,327.59 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (HKD MM)

Pre-Tax Profit

Highest at HKD 1,370.01 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 1,131.73 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (HKD MM)

EPS

Highest at HKD 1.15

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Inventory Turnover Ratio

Highest at 3.9%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 37.75%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation

Highest at HKD 31.06 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 31.06 MM has Grown at 37.48%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Giant Biogene Holding Co. Ltd.

Interest

At HKD 0.2 MM has Grown at 237.76%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Interest Coverage Ratio

Lowest at 661,511.89

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit Margin

Lowest at 40.82 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales